Showing results (161-170 of 213) with videos related to
Sort By:
Pageof 22
Journal of Affective Disorders|September 23, 2008
A missense variant (P10L) of the melanopsin (OPN4) gene in seasonal affective disorderKathryn A Roecklein, Kelly J Rohan, Wallace C Duncan, et al.Psychopharmacology|August 4, 2004
Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5' nuclease assayGuanshan Zhu, Robert H Lipsky, Ke Xu, et al.Amino Acids|September 26, 2006
Preconditioning and neurotrophins: a model for brain adaptation to seizures, ischemia and other stressful stimuliA M Marini, X Jiang, X Wu, et al.Journal of Neuroscience Research|March 4, 2005
N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathwayDaming Zhu, Xuan Wu, Kenneth I Strauss, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 14, 2011
The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injuryFrank Krueger, Matteo Pardini, Edward D Huey, et al.The Pharmacogenomics Journal|January 4, 2007
Nucleotide sequence variation within the human tyrosine kinase B neurotrophin receptor gene: association with antisocial alcohol dependenceK Xu, T R Anderson, K M Neyer, et al.Journal of Neurochemistry|August 4, 2004
AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expressionXuan Wu, Daming Zhu, Xueying Jiang, et al.Pharmacology|March 11, 1998
Benzylacyclouridine enhances 5-fluorouracil cytotoxicity against human prostate cancer cell linesL K Yee, E Chu, B C Pan, et al.Dose-Response : a Publication of International Hormesis Society|October 21, 2011
Cellular and molecular responses of cultured neurons to stressful stimuliJun Chen, Hongna Pan, Robert H Lipsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminomaW J Reiter, T Brodowicz, S Alavi, et al.Pageof 22